Gain Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Great. Thank you, operator. As always, a real pleasure the way you make it all so easy for us, the folks behind the screen. Thank you so much.
Matthias is joining us from Gain Therapeutics. Matthias Alder is the CEO of Gain Therapeutics and somebody I've known for a while. And Gain Therapeutics is a company we have a distinct interest in because they're trying to do some things that are fairly unique in the industry. And Matthias will give us an update as to what exactly that is. We'll go for about 20, 25 minutes, and then have time for some Q&A after that. So Matthias, please.
Great. Thank you, Hartaj, for having me. And thanks to Oppenheimer for organizing the conference, and thanks for everybody dialing in with -- to learn more about Gain Therapeutics and what we're up to.
We're a publicly traded company, so here are our forward-looking statements. So if you make investment decisions, please keep the risks in mind that we face in our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
